The nine-page booklet is being distributed electronically to all BEVA members, together with a guide on spotting some of the warning signs horses may display, written by equine veterinary surgeon and behaviourist Gemma Pearson.
A report commissioned by the BEVA in 2013 indicated that an equine vet could expect to sustain between seven and eight work-related injuries that impeded them from practicing, during a 30-year working life.
Data available from the Health and Safety Executive suggests that this is a very high number of injuries compared to other civilian occupations, including those working in the construction industry, prison service and the fire brigade.
The new guide has been produced ‘by horse vets for horse vets’ with BEVA members contributing their views, experiences and suggestions to early drafts.
It provides information for those handling and involved with equine veterinary care; to make workers consider the steps that they can take to make their activities as safe as reasonably possible by assessing a situation and implementing measures to limit the risk that vets and others are exposed to.
The guide also aims to challenge prevailing attitudes and culture. It outlines how to make ‘on the spot’ or ‘mental’ risk assessments and when to stop if a procedure becomes unsafe.
The guide is accompanied by an illustrated leaflet Signs of Increased Arousal Combined with a Negative Effective State. Written by Gemma Pearson, BVMS Cert AVP (EM) MRCVS who specialises in equine behaviour and learning theory, it explains signs of increased arousal including facial expressions, stance, movement and response.
David Mountford, CEO of BEVA said: "The new guidelines have been carefully developed to ensure that they are as pertinent, pragmatic and helpful as possible for vets in practice. Hopefully they will help to make the equine veterinary workplace a little safer."
The new guides can be downloaded at: https://www.beva.org.uk/workplacesafety
The 8-week study1, which was part-funded by the ISAZ/Waltham Petcare Science Institute Collaborative Research Award and Canines Providing Assistance to Wounded Warriors (C-P.A.W.W.), compared the effects of walking with a shelter dog vs. walking with a human and the impact they had on psychological stress indicators, PTSD symptoms and the stress in reintegrating military veterans.
The veterans in the study who walked with shelter dogs experienced improved rate variability and decreased levels of salivary cortisol – both signs of relaxation and improved stress response.
Waltham points to a Journal of Psychiatric Research estimate that up to 25% of military veterans who have transitioned out of active duty would meet the criteria for a diagnosis of PTSD2. This, says the Institute, could mean that up to 625,000 of the 2.4 million3 military veterans currently living in the UK could potentially be living with this mental health issue.
Dr Kay O’Donnell, Ph.D., Vice President of the Waltham Petcare science institute, said: “This study further highlights the potential of dog walking to improve the lives of both veterans and shelter dogs by offering veterans a way to make a difference in the lives of shelter animals – while dogs are simultaneously helping veterans with symptoms of PTSD.
"At the Waltham Petcare Science Institute we believe we have a responsibility to take scientific exploration further when evidence to date shows us that pets can be part of addressing conditions like PTSD. It’s important we undertake rigorous studies to understand how companion animals may provide a benefit and we’re proud to be part of this study, which takes us another step forward in understanding the human-animal bond."
References
The company says it has renamed the product to better reflect its main use, which is for maintaining skin and coat health in cats and dogs.
Chris Jones, Managing Director at Nutravet said: “We’re continually looking at ways to improve our product offering, which includes ensuring our product range can be discussed with ease between veterinary professionals and pet owners.
"Nutracoat has been used in international markets since launch, and we now feel that the natural progression is to mirror transition the use of Nutramega to Nutracoat in the UK."
www.nutravet.com
The company says it has been working hard to ensure improved supply on a number of brands including Apoquel, Palladia and now Trocoxil, with animal welfare being the key consideration at all times throughout this process.
Ned Flaxman, business unit director for companion animal, equine and innovation at Zoetis said: “It was a really difficult decision to stop production of Trocoxil in favour of Apoquel and Palladia but we felt that it was the right thing to do on animal welfare grounds. As soon as we had full stocks of these products we resumed the manufacture of Trocoxil and I am delighted to say that it will be back in stock in December.
"I would like to thank our veterinary clients for their patience and reassure them that we brought the product back to market as quickly as we could and do not anticipate any further stock issues."
Trocoxil chewable tablets are used for the treatment of pain and inflammation associated with degenerative joint disease in dogs aged 12 months or over.
For more information, contact your Zoetis account manager.
The project was 'highly commended' at the RCVS Knowledge 2024 awards.
The CVS clinical improvement project found that a major barrier to conducting ultrasound scans was a lack of confidence - both in using equipment and interpreting images.
A recent Canadian industry study has also reviewed barriers, citing a lack of equipment, training and skills as root causes1.
The ultrasound project aimed to review practice equipment, improve clinician case identification, increase clinical skills and confidence, and recommend ultrasound in all appropriate cases.
The company put together resources for vets and nurses designed to help improve ultrasound scan rates, including clinical guidelines, webinars for how to approach cases, and machine guides.
CVS then held training sessions which for vets focussed on case identification and improving diagnostic skills, and for vet nurses looked at how to use ultrasound equipment and conduct scans.
An audit of each participating practices’ ultrasound scan rates was conducted at the start of the project. Results were then shared with each practice every month.
Twelve months after launch, data shows that the number of ultrasound scans has increased by 3,675.
Anecdotal evidence has also shown that colleague confidence and practice team culture has improved as a result of the project.
Dr Victoria Woods, Regional Clinical Lead at CVS responsible for the ultrasound clinical improvement project, said: “It’s fantastic to see the benefits increased ultrasonography is already bringing to our practices on this project – especially as a result of upskilling our nurses.
"I am certain that this will help contribute towards them providing some of the best clinical diagnosis and care in our profession.”
Following the success of the project in its first year, the project is now being developed to focus on echocardiograph and is being undertaken in 52 CVS primary care practices in year two.
Reference
VetSurgeon.org has published a light-hearted practice waiting room poster designed to help pet owners learn good 'vetiquette'
The idea came about after Hamilton-based Julie Innes MRCVS shared a poem she'd written to display in her own practice waiting room in the VetSurgeon.org forums. It was such a gem that VetSurgeon.org commissioned Joe Wright, the illustrator behind the much loved 'What a Mess' children's books, to bring Julie's poem to life.
The resulting poster (pictured right; click to enlarge) is now available to buy on Zazzle (https://www.zazzle.co.uk/vetstuff), priced at £10.45 +P&P for an A2 version and £9.40+P&P for the A3 version.
The price includes a 5% royalty, which will be donated to the Veterinary Benevolent Fund (VetLife).
There is also a collection of VetSurgeon.org and VetNurse.co.uk exclusive coffee mugs (£10.30 +P&P), bearing cartoons from the poster. Again, the royalty on sales of these mugs will be donated to the VBF.
The poster has also been published on VetSurgeon.org's Facebook feed, so it can be shared on practice Facebook pages.
The RCVS Disciplinary Committee has dismissed an application to be restored to the Register of Veterinary Surgeons from former Wirral-based vet Ian Beveridge.
In May 2013 the Committee had asked the Registrar to remove Mr Beveridge from the Register following a four-day hearing in which he was found guilty of serious professional misconduct after finding that he had treated clients badly, kept inadequate clinical records, was dishonest in his dealings with the RCVS and that animals in his care were placed at risk.
In June 2013 Mr Beveridge, who was not present or represented at the original hearing, then appealed the decision. The appeal was withdrawn in May 2014 which was when Mr Beveridge was formally removed from the Register.
Then, in April 2015, Mr Beveridge applied to be restored to the Register. The Disciplinary Committee met to consider his application in June 2015, however, this hearing was adjourned after new evidence was served to the Committee concerning allegations that Mr Beveridge had ordered prescription-only veterinary medicines when he was not authorised to do so. He was subsequently interviewed by police who took no further action.
In deciding whether Mr Beveridge was fit to be restored to the Register, the Committee heard evidence in regards to the circumstances in which the prescription-only drugs were ordered using his account and delivered to his former practice address which had been taken over by Medivet after he sold the premises to the company.
During the course of the hearing, Mr Beveridge admitted that his account had been used to buy the drugs, but that a part-time member of his staff, who was neither a veterinary surgeon nor a veterinary nurse, had done so without his prior knowledge or approval.
In relation to this evidence Ian Green, chairing and speaking on behalf of the Committee, said: "The Committee takes the view that the unauthorised use of a veterinary surgeon’s drugs account for which he carries the ultimate responsibility is a very serious matter and, of itself, demonstrates that the applicant has at best a cavalier attitude to his work which of itself means that he remains unfit to be on the Register.
"This attitude is further demonstrated by the fact that, even after the first orders were placed in late April and early May 2014, the applicant did not seek clarification from the College of his status following the withdrawal of his appeal against the original Committee’s findings."
In addition to this, the Committee also considered the seriousness of his original failings, the fact that Mr Beveridge’s acceptance of these failings was ‘qualified’, that he had been off the Register for 20 months and the fact that his efforts in terms of continuing professional development had been inadequate and not focused on those areas in need of improvement, among other factors. In mitigation it did consider that Mr Beveridge had demonstrated genuine remorse about previous actions and noted a petition and a large number of letters in support of him from former clients of his practice.
However, the Committee felt that this did not detract from the seriousness of the original failings and, in conjunction with the subsequent unauthorised ordering of veterinary drugs, that the application for restoration must be dismissed.
The Royal Veterinary College has carried out the first ever open-heart surgery to treat a stenotic tricuspid valve in a dog.
The three-year-old Labrador, Mabel, suffered from congenital tricuspid dysplasia. She was referred to cardiology specialists at RVC Small Animal Referrals where her tricuspid valve was found to be completely fused in the middle, with just two very small openings for her blood to flow through.
In a procedure that took a little over an hour, the RVC team examined and worked on the valve. The College reports that Mabel’s surgery was a success and her stenosis was relieved.
Mabel was subsequently found to have a moderate amount of regurgitation into the right atrial chamber, but after a few more days of additional monitoring at the RVC she was able to return home.
The surgery was carried out by Professor of Small Animal Surgery Dan Brockman at the Queen Mother Hospital for Animals. He was assisted by a team of RVC specialists to provide pre and post-operative care, including a perfusionist, a team of three anaesthetists, two surgery nurses, three surgeons and a cardiology veterinary specialist-in-training. In addition, Professor of Veterinary Cardiology Virginia Luis Fuentes and veterinary specialist-in-training Dr Rosie Payne were members of the Cardiology Service’s investigation into Mabel’s condition.
RVC students were also involved in the Mabel’s initial examinations at the hospital, providing them with an insight into the procedure. The examinations included cardiac ultrasound using the newest generation of cardiac ultrasound equipment, which is able to capture 3D and 4D images. The new ultrasound scanner was funded in part by the RVC’s charity, the Animal Care Trust.
After the surgery, the emergency and critical care (ECC) team and the Cardiology Service took over Mabel’s care, with Professor Brockman remaining involved. This saw up to four senior ECC clinicians, a number of veterinary specialists-in-training and half a dozen highly trained ECC technicians working in shifts around the clock to care for Mabel and ensure a good recovery.
According to the RVC, there have been previous attempts by veterinary surgeons to open stenotic valves with balloon valvuloplasty. However, because it is very difficult to tear the stenotic valve, this approach has not proved very successful. There is also a high risk when putting canines onto bypass. Canines have fragile blood vessels, and cannulae need to be inserted into several of these vessels, creating a danger that a major vessel tears.
Commenting on why the RVC team decided to perform this procedure at this point, and on Mabel, Dan said: "Lots of things fed into this decision. First and foremost, we had a patient whose pathology made surgery the best solution. I explained to the owner and was very honest that this procedure would be really breaking new ground. Based on what the human paediatric cardiac surgeons will do, and our limited experience of balloon-valvuloplasty suggests this is the best approach for these dogs
"The operation itself is risky, much worse than most other operations. In our hands, for this type of disease, we have about an 80% chance of getting them through the procedure. The owner has to gamble what life the dog has left against the promise of a more normal quality of life and life-span following the operation."
In relation to Mabel’s prognosis if the surgery had not been undertaken, Professor Luis Fuentes said: "It is likely that the signs of right-sided heart failure would have been more difficult to control. Her ability to exercise would have become less and less, and she would have also been at risk of having abnormal heart rhythms associated with the enlargement of the right atrium. Generally we expect them to develop more and more signs as the disease progresses. These are difficult cases to manage on a long-term basis with drugs. Her life expectancy would have been substantially reduced.
"I thought Mabel was almost a perfect candidate to have the procedure here as Dan has a lot of experience replacing tricuspid valves in dogs with tricuspid dysplasia. In those cases there is usually leaking, but Mabel’s case was unusual in that she has minimal leaking and she was most affected by the stenosis. That means you may not have to implant any additional valve structure."
Speaking two weeks after the operation, owner Annabelle Meek, from Melton Mowbray, said: "Mabel has just come back in from wandering around the perimeter of my garden for the first time since before the operation. It’s more than half an acre and she has been ambling around happily following a scent.
"I would like to thank absolutely everybody. It’s been an enormous team effort on all sides. Every single person I met at the RVC, from the man on the gate to all the hospital staff, was so friendly. After she came home Dan Brockman phoned me every day to see how she was doing. The RVC should be very proud of what they have done for Mabel."
The group says it has led to 6,086 more clinical metrology questionnaires being conducted at participating practices with their patients, a 1,014% increase.
Developed by John Innes at the University of Liverpool, the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire is a 13-item clinical metrology instrument (CMI) used to assess canine articular disorders like osteoarthritis.
It includes questions on the pets’ medical background, lifestyle and mobility.
Individual question scores are summed to provide an overall “LOAD score” suggestive of the animal’s disease presence and severity.
The questionnaire should be conducted every time the pet is presented to the veterinary clinic, with results tracked over time.
Treatment options - including the benefits and risks of all available modalities – can then be considered and discussed with owners to determine the best course of action, including weight management, diet, supplements, exercise and environmental modification, in addition to medication.
As part of the project, CVS provided a range of supporting resources for its practices, together with training.
Training focussed on diagnosing and managing conditions causing lameness in dogs and cats, using the clinical metrology questionnaire to engage clients in their pets’ treatment plan, offering best practice treatment options and running nurse mobility clinics.
It comprised of a vet CPD day run with Zoetis and the VOA on approach to and management of lame patients, two nurse CPD days on mobility clinics, a feline and canine orthopaedic examination video, First Opinion Clinical Club webinars on canine and feline osteoarthritis and an approach to radiographic interpretation course.
Resources included: new clinical guidelines, IMV resources (radiographic positioning, optimising the image and optimal chemical restraint) and a Mobility Clinic Booklet for clients.
Each site was then provided with its own data, so that they could monitor what they were doing individually.
One year after its nation-wide launch, results reveal that the number of clinical metrology questionnaires being conducted in the 35 participating practices has increased from 6 to 6,092 over a 12 month time period.
CVS says there was also evidence of an increasing incidence of the osteoarthritis drugs Librela and Solensia being prescribed.
Kathryn Patel, Hub Clinical Lead at CVS (pictured), who was responsible for the lameness clinical improvement project, said: “This project uses owner questionnaires to screen for and monitor the impact of lameness on patient quality of life and emphasises the importance of the whole clinical team in patient management.
"Vets and nurses will be supported to improve their ability to reach a diagnosis in every lame case, improve engagement with and compliance of owners with lame pets, and improve the quality of care of lame patients through appropriate medication, surgical intervention, and nurse and physiotherapy support.”
Linda gave her address at the Royal Institute of British Architects, venue for the RCVS Annual General Meeting last Friday.
Linda, an equine vet and director of the Wiltshire-based George Veterinary Group, said: “A Royal College and a regulator – it’s a challenge but this combined role is also an opportunity for us.
“In the time I’ve served the RCVS, I’ve definitely learnt some of what it takes to fulfil these roles under the remit of both the Veterinary Surgeons Act and our Royal Charter; to think not just from personal perspective and experience, and also to try to look beyond the needs of the profession today and consider what tomorrow might bring.
“Vets are not just one thing.
"The roles we fill in our working lives are many and varied, and I would argue that the MRCVS is the best placed arbiter of animal health and welfare.
"As such, keeping the MRCVS at the heart of decision-making around how veterinary care and services are provided is essential both to safeguard animal health and welfare and also to retain public trust in our work.
“Cultivating trust is a big part of what many of us do, day in and day out – trust in us from within our teams, from our clients and perhaps even from our patients.
“The RCVS with its two hats does a tough job for both the professions and the public.
"In many cases, the interests of the professions and the public align and there is no conflict.
"Of course, as a regulator where the interests don’t align, the RCVS regulates in the wider public interest and this, too, is a positive for us as a profession.
“Working in a regulated environment is a strength for us.
"The landscape in which we work has changed and the regulatory environment needs to change too. Now we are the other side of the general election, work can continue on legislative reform seeking parliamentary time for a new Veterinary Surgeons Act.”
As the 13th female President of the RCVS, Linda will lead an Officer Team comprising the now Senior Vice-President Dr Sue Paterson FRCVS, Junior Vice-President Professor Tim Parkin FRCVS and Treasurer Dr Tshidi Gardiner MRCVS as well as VN Council Chair Belinda Andrews-Jones RVN, who attends Officer Team meetings as an observer.
Two recently published studies have demonstrated that the canine anti-emetic Cerenia® (maropitant - Pfizer) which was launched last year also relieves car sickness in dogs.
In a pilot study, 17 dogs were given either Cerenia or placebo one hour before being taken on a car journey. After a washout period of 10-14 days, each dog was crossed over to the other treatment and once again taken on a journey to assess travel sickness. The results showed that likelihood of vomiting was reduced by 70% when the dogs were given Cerenia compared to placebo – but due to the small number of dogs enrolled the results did not reach statistical significance.
The same research group also carried out a large, multicentre, blinded and placebo controlled study of Cerenia in preventing vomiting in 213 dogs known to be prone to travel sickness. They were given a single oral dose of Cerenia or placebo one hour before a car journey. The results showed that Cerenia was associated with a reduction in vomiting of 79% compared to placebo (p<0.0001).
The dosage of Cerenia used in both studies was 8mg/kg dose for the prevention of motion sickness–higher than the 2mg/kg dose that is routinely used to treat general emesis, administered at least one hour before the journey. According to the researchers’ report in the Veterinary Record, the need for a higher dose is linked to the specific neural (central) pathway of emetic stimulation that is involved in motion sickness. Cerenia acts primarily at NK1 receptors in the emetic centre and thus has the ability to block vomiting due to vestibular stimuli.
According to Pfizer, a single oral dose lasts for at least 12 hours, so pets can be dosed the night before an early start. For motion sickness prevention, Cerenia is licensed for up to 2 days’ consecutive use, so owners can use it for a return journey the next day if need be.
Pfizer also says that market research suggests almost one in five dogs suffers from travel sickness, which is not only inconvenient but does also stop some owners from travelling with their pet. In the past, owners have had to rely on OTC (over the counter) remedies or medicines developed for use in humans to prevent travel sickness. Many of these are ineffective or have unwanted effects such as sedation or extrapyramidial effects in dogs. Cerenia is the first anti-emetic to be developed specifically for use in dogs and was launched in April 2007– higher dose tablets aimed specifically for the prevention of travel sickness are expected to be made available early this year.
It seems that a series of one day conferences, organised by the Animal Health agency for vets and animal health inspectors involved in fighting bovine TB, haven't gone down as well as hoped.
According to a report in yesterday's Daily Telegraph, many in the audience were angered when they were asked to spend up to an hour playing a game involving bongo drums.
Incredibly, a spokesman for Animal Health apparently told the Daily Telegraph that: "It was meant to emphasise how people working together can build up a rhythm."
Petplan is calling for nominations for this year's 'Petplan Pet Insurance Advisor Award'.
The award is to recognise the hard work and dedication that Pet Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially. You can nominate a PIA at your practice by visiting www.petplan.co.uk/pia. The winner will receive a new laptop and their practice will receive £100 in vouchers.
Petplan Marketing Manager Alison Andrew said: "At Petplan we are proud to recognise the dedication and hard work that Pet Insurance Advisors put in to give their customers informed and up-to-date advice. So please get your nominations in!"
Nominations close on 3rd September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress on 9th October.
The programme includes more than 130 hours of CPD delivered by over 100 speakers from home and abroad, with talks for all members of the practice team.
The UK speakers include Rebecca Geddes on kidney medicine and nursing; Amy Newfield on IV access techniques; Rob White on brachycephalic surgery and acute abdomen surgical techniques; Penny Watson on liver disease; Dick White on the surgical team; Butty Villiers on cytology for vets and nurses; John Chitty on several rabbits, small furries and exotics topics.
BSAVA President, Professor Ian Ramsey, said: “Following months of meticulous planning we are thrilled that the programme is now live
"The sheer range and high quality of our speakers and content, together with our new, more dynamic format takes webinar learning to a new level."
“Delegates will be able to develop their skills and knowledge on topics they see regularly in practice. To make things even easier we will be providing practical resources such as client handouts for delegates to take back to their clinics. This, coupled with many speakers sharing their own notes and practical resources means less note-taking and a quicker and easier way for delegates to share what they have learnt with their colleagues.”
There will be three keynote speakers; Jenny Campbell, a former Dragon on BBC’s Dragon’s Den, will be sharing her experiences as an entrepreneur and business leader. Two other keynote names will be announced shortly.
On the social side the focus is on bringing people together online to share light-hearted entertainment and laughter. Delegates can exercise their taste buds with some wine and whisky appreciation, throw some shapes with a virtual disco, exercise their bodies as well as their minds with yoga and unwind with some restorative meditation practices.
Ian added: “This year’s BSAVA Congress is going to be the most innovative ever and deliver like never before. There is plenty of relevant and engaging CPD for every practice professional, with all the convenience of a virtual event. If you haven’t already taken a look at the programme and registered, I urge you to do so now. With prices starting at just £99 +VAT for members it represents really great value.”
To register now visit https://www.bsavaevents.com/bsavacongress2021/en/page/home
A team of researchers led by Tim Mair, CVS Equine Veterinary Director and Specialist in both Equine Internal Medicine and Equine Soft Tissue Surgery at Bell Equine Veterinary Clinic, will review 100 cases of colitis in adult horses and 100 controls referred to seven equine veterinary hospitals in the UK: five CVS equine veterinary hospitals as well as Rossdales Equine Hospital and University of Liverpool’s equine hospital.
A set of diagnostic tests on blood and faeces will be performed in these cases.
The laboratory tests will include: small redworm serology, culture and PCR of faeces for Salmonella spp, PCR of faeces for Clostridioides difficile and Clostridium perfringens, ELISA of faeces for toxins of C.difficile and C.perfringens, PCR of faeces for coronavirus.
The clinical features, laboratory results, treatments and outcomes will also be recorded.
Tim said: “Acute colitis accounts for around 5% of admissions to referral hospitals.
"And of those who are referred with it, half will not survive but there is very limited evidence available.
"So it’s vital that we build our evidence-base of this life-threatening condition.
"We hope that the outcomes of our new study will lead to a greater understanding of the causes and better inform veterinary treatment of colitis in UK adult horses.”
The Colitis in Adult Horses study is supported by a research grant from CVS, and funding for the small redworm ELISA will be given from Austin Davis Biologics.
The study started at the beginning of 2024 and the first horses have been recruited.
The results of the study are expected to be published in 2025.
Petplan has announced the finalists for the inaugural Petplan and Association of Dogs and Cats Homes (ADCH) Animal Charity Awards.
The awards have been set up by Petplan to celebrate the outstanding work of animal charities and not-for-profit organisations across the UK.
The finalists for each of the categories are:
Animal Charity Team of the Year
Animal Charity Volunteer of the Year
Animal Charity Employee of the Year
Simon Masding, Petplan's Head of Sales and Partnerships said: "Animal wellbeing is central to all we do at Petplan. We work with over 1,500 animal charities and give over £2million to assist them every year. The Petplan and ADCH Animal Charity Awards is another way for us to support and recognise the teams and individuals at charities dedicated to improving the lives of animals. We're delighted that these new awards have got off to a fantastic start with over 3,400 nominations from adopters, supporters, charity staff and volunteers."
Winners will be announced on the 2nd May in an awards ceremony in Stratford-upon-Avon. For further information go to www.petplan.co.uk/charityawards
The association says the qualification will help vets conduct clinical research relating to their work - in particular vets working in practice. It is aimed at people who already have any accredited postgraduate certificate (60 credits at Level 7) relevant to some aspect of veterinary medicine or surgery and are keen to develop a deeper understanding of their research topic.
The Masters starts with online study into the principles of clinical research, which students then apply to their own research project, based on a further 1,200 study hours that could be flexibly achieved in two years of part-time study or up to five years, depending on the project type and an individual’s availability.
Lucie Goodwin, BSAVA Head of Education (pictured right), said: "For those vets who have already completed a postgraduate certificate it is an opportunity to develop their skills further, partake in research and collect valuable data from the field. So much of the published data in veterinary journals is based upon a referral population and this may not necessarily reflect what truly happens in clinical practice."
She added: "The BSAVA Masters is designed to appeal to vets who want to undertake research alongside their job role, without having to commit to a full-time programme of study."
Students will be allocated a ‘matched’ supervisor to provide project advice and guidance, plus the BSAVA team will be on hand to ensure ongoing support and encouragement.
Johanna Forsyth, senior veterinary technical manager with the diagnostic laboratory Avacta Animal Health, joined the Masters programme when it launched in 2016. She said: "The thing that has given me the most satisfaction from taking part in this programme is the way my views have changed. I look at things I wrote a little while back and think: 'Did I really say that?'. You become so absorbed in the project that you don’t notice how your understanding of the topic has grown. It’s so subtle, we haven’t been force-fed anything - it’s just like osmosis."
For more information, please contact masters@bsava.com or visit the website https://www.bsava.com/Education/Masters
The study titled “Electrolyte measurements differ between point-of-care and reference analysers in dogs with hypoadrenocorticism” investigated the performance of two point-of-care analysers (IDEXX Catalyst Dx and IDEXX VetStat) against a reference laboratory method for the measurement of blood sodium, potassium and chloride concentrations, as well as sodium-to-potassium ratios, in dogs diagnosed with and treated for hypoadrenocorticism.
Forty-eight dogs with hypoadrenocorticism were enrolled into a prospective cross-sectional study at the University of Glasgow. In total, 329 paired samples were measured on the Catalyst analyser and by the reference laboratory method called an ion selective electrode (ISE), while another 72 paired samples were tested on both the VetStat analyser and by ISE. The clinical effects of any difference in the electrolyte results were investigated.
Sam Fowlie, corresponding author for the paper, said: “Our results indicate that the sodium, potassium and therefore the sodium-to-potassium ratios, as well as the chloride concentrations measured by the Catalyst and VetStat analysers may not be used interchangeably with those from a reference laboratory analyser using an indirect ISE method. Both analysers tended to give higher results than the reference method for all analytes, except for potassium when measured on the VetStat.”
The clinical relevance of the disagreement between these methods was investigated by assessing how often the point-of-care analysers produced results which fell outside their reference range when the ISE method found them to be within reference and vice versa. For the Catalyst, there were 21 cases (6%) with discordant sodium results, 27 cases (8%) with discordant potassium results and 46 cases (14%) with discordant chloride results. The VetStat, meanwhile produced results which disagreed with the ISE method in 19 cases (26%) for sodium, 3 cases (4%) for potassium measurement and 9 cases (13%) for chloride analysis.
Nicola Di Girolamo, Editor of JSAP added: “This study reveals significant systematic differences (“bias”) between the three analysers in this study. Comparing numerical results from different analytical methods – be they point-of-care or reference laboratories – can be dangerous for patients. Clinicians should always use method specific thresholds and, if these are not available (for example the sodium-to-potassium ratios on some analysers), then they should exercise greater caution in their interpretation.”
The full article can be found in the October issue of the Journal of Small Animal Practice and be read online here, open access: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13205.
Photo: Ian Ramsey
The extension, which is due for completion before the end of the year, will allow the centre to offer a range of new services, including a new radioactive iodine unit for treatment of hyperthyroidism in cats, a larger echocardiography suite for cardiac patients, an endoscopy suite, an ophthalmology procedure room, a dedicated operating theatre for minimally invasive procedures and 41 new kennels.
Toby Gemmill, clinical director at Willows, said: "The expansion represents a really exciting time for Willows and has been carefully planned to maximise the space we have available to us.
"We are already extremely well placed to offer a wide variety of specialist treatments and this extension will provide us with the space to build on our gold level cat-friendly clinic status with a radioactive iodine unit for treatment of hyperthyroidism in cats, along with dozens of new kennels and range of specialist treatment rooms."
The extension is part of a major investment drive by the Linnaeus Group, of which Willows is a part, which will see it plough around £9 million into its sites across the UK.
Lynne Hill, chief executive of the Linnaeus Group, said: "We are extremely proud of the practices within the group and are fully prepared to support them financially, and in any other way, to ensure they continue to offer the very best facilities and treatment for our clients and patients."
RCVS Knowledge launched the Canine Cruciate Registry on the Amplitude pro registry platform last year.
The automated registry, the first of its kind in veterinary medicine, allows the profession to evaluate the success of surgical techniques, and practitioners to benchmark their performance.
In June, RCVS Knowledge had a poster detailing the purpose, impact and aspirations of the registry accepted at the PROMs research conference, which before now typically only accepted submissions from the field of human medicine.
This, says Amplitude, marks the first step in sharing information about running registries designed to identify best practice in the care and treatment of both animals and people.
Chris Gush, Executive Director of RCVS Knowledge, said: "RCVS Knowledge is proud to be leading the development of clinical audit and registries to support the veterinary professions on their journey to continually improve the care they deliver.
"Registries are key in supporting the professions in understanding first-hand information about our patients with certain conditions, both individually and as a group, contextualizing with information from their owners, and over time, to increase our understanding of that condition.”
The Animal Medicines Training Regulatory Authority (AMTRA) is launching its new Continuous Professional Development (CPD) scheme today, designed to ensure that the Authority's registered Suitably Qualified Persons (SQPs) keep up to date with the latest animal medicines information.
In order to maintain their SQP status, every SQP will have to achieve a minimum number of CPD points during each AMTRA CPD period, running for two years from July to June. However, in the initial stages of the scheme, this first period will run for 33 months, from October 2008 to June 2011, allowing AMTRA to fine tune the system if required and give its SQPs time to get used to the new structure.
During these CPD periods, SQPs are required to obtain a minimum number of CPD points depending on their SQP type:
SQP Type: Modules; VPS medicines supplied; CPD PointsR-SQP: FAM+EQM+CAM; All VPS Medicines; 70 pointsG-SQP: FAM+EQM; VPS-farm animals and equines only; 50 pointsK-SQP: FAM+CAM; VPS-farm and companion animals only; 50 pointsE-SQP: EQM+CAM; VPS-equines and companion animals only; 50 pointsL-SQP: FAM; VPS-farm animals only; 30 pointsJ-SQP: EQM; VPS-equines only; 30 pointsC-SQP: CAM; VPS-companion animals only; 30 points
(FAM - Farm Animal Module, EQM - Equine Module, CAM - Companion Animal Module)
In essence, this means that 20 points are required per animal group, plus a further 10 points. Dr Roger Dawson, Secretary of AMTRA comments, "There is no maximum number of CPD points that SQPs can accumulate and we will be encouraging them to gain the benefit of as much CPD as they can."
Those SQPs who do not achieve the minimum number of CPD points by the end of the period will not be eligible to renew their status for the following year. However, such SQPs will have the option of sitting an examination before the end of that CPD period in order to maintain their SQP status and eligible be to renew for the next year.
SQPs will have a range of avenues through which to gain CPD points, ranging from four types of AMTRA-accredited CPD Events, to online study and personal study. With CPD Events and online studies, accreditation and points will be awarded by the AMTRA CPD Accreditation Panel. With personal study, AMTRA accepts a degree of self-certification of this form of CPD, however the points gained in this way are limited to a relatively small proportion of the minimum required in a CPD period.
Throughout a CPD period, all SQPs are required to attend at least ONE CPD Event. These events will comprise a range of modules that will be assessed for coverage, of relevant topics ranging from legislation, regulations and prevalence & effects of parasites and pathogens, to control of disease management, resistance, warnings and SARS.
Dr Dawson says, "The new CPD scheme has the necessary flexibility to allow SQPs to gain the required CPD points via a number of routes, from accredited CPD events and online study to personal study. Furthermore, the structure of the scheme ensures that their studies will be properly assessed to ensure they have gained the necessary knowledge to secure their CPD points."
The RCVS Disciplinary Committee has directed that a Leeds-based veterinary surgeon, whose convictions for threatening behaviour, theft, and assault made him unfit to practise, should be removed from the Register.
At the outset of the two-day hearing, Dr Gary Samuel admitted his convictions. These related to his actions near his property in Cardiff on 10 July 2011, and were received at Cardiff Magistrates' Court on 22 November 2011. The Committee was asked to decide if these convictions made Dr Samuel unfit to practise veterinary surgery, and to decide upon any sanction.
The facts of the offences, as set out at the magistrates' court by the prosecution, were that Dr Samuel took a camera and memory card from a neighbour who was taking photographs of construction works behind his property. In doing so, he grabbed the neighbour from behind, twisting her arm, and later threatened her and her partner with a large piece of wood.
Although Dr Samuel wrote to the College saying he had pleaded guilty to the charges, he also denied some of the offences charged, suggesting that it was the neighbour who had been abusive towards him.
The Committee allowed the possibility that Dr Samuel was provoked by the taking of photographs and may have been subjected to offensive abuse by the neighbour, and considered that he acted impulsively and lost control of his actions. However, the convictions were for serious offences: the assault resulted in injury to the victim; the threatening behaviour involved a risk of injury to the victim and her partner; and, the theft involved dishonesty. Dr Samuel's conduct at the time was "reckless", and he had since displayed very limited insight into his behaviour.
Professor Peter Lees, chairing and speaking on behalf of the Committee said: "The Committee considers that the offences of which the Respondent was convicted, and to which he pleaded guilty, were serious, as is reflected in the suspended sentences, community service orders, fines, restrictions and penalties imposed by the court. The Committee accepts that this is not a case in which the welfare of animals has been put at risk, but takes the view that a serious sanction is required in order to uphold the reputation of the veterinary profession, and public confidence in it, and to uphold proper standards of conduct and behaviour on the part of its members."
The Committee directed Dr Samuel's name should be removed from the Register.
The Veterinary Development Council (VDC) is conducting a survey to investigate the role of paraprofessionals and technicians in veterinary practice, and is asking vets in large animal, equine, and mixed practices to complete a short survey.
The VDC says that information from the survey will help inform discussions on the regulation of technicians.
The survey will take between 5 and 10 minutes to complete and can be found on the BVA website at www.bva.co.uk/vdc. The BVA has also emailed the survey directly to practices.
The survey has been devised by the VDC working group looking at the role of the veterinary-led team, chaired by BVA Past President Professor Bill Reilly. This is one of three working groups that will report to the VDC:
Professor Reilly said: "The relationship between veterinary surgeons and technicians is vital but it varies from practice to practice.
"The working group on the role of the veterinary-led team aims to take a snapshot of how services, such as artificial insemination and foot trimming, are currently delivered, and gauge how veterinary surgeons feel about other services being delivered by non-veterinarians in the future.
"I hope veterinary surgeons in large, mixed and equine practice will take 10 minutes to complete our survey to help us map the current use of technicians in veterinary practice and help shape our future discussions."
Vetsonic has taken over the marketing of Cavalesse, the oral nutritional supplement for horses that are prone to skin allergies, such as sweet itch.
Cavalesse contains a formulation of water-soluble vitamins and minerals, administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat. Vetsonic claims the supplement helps horses maintain a healthy skin and promotes normal immune function.
Ray Rochester, Managing Director of Vetsonic said: "It's an exciting phase in the development of Vetsonic which will see us rapidly expanding in the increasingly competitive small animal and equine market. Cavalesse is a welcome addition to our portfolio."
For further information, contact Vetsonic customer services on 01653 695333.
Boehringer Ingelheim Vetmedica has announced that it will be launching Bovela, a new viral diarrhoea (BVD) vaccine, to farmers during April 2015.
Allan Henderson from Boehringer said: "BVD remains the most common viral disease affecting cattle throughout Europe, despite vaccines being available for over 15 years. We asked farmers why this was the case and, without exception, they remarked that current vaccine protocols are unwieldy, requiring precise timings making them hard to follow.
"Bovela is a unique one-shot vaccine that can be used in cattle from three months of age and also whether pregnant or not. Other, currently available vaccines require a two-dose primary course with boosters annually or even every six months thereafter."
BVD is spread within herds and to new herds through the presence of persistently infected (PI) animals. PIs can look relatively healthy and show no outward signs of infection but, as they were exposed to the virus as a foetus, have become virus carriers. If they are born alive, they will shed virus consistently throughout their lives so perpetuating the cycle of infection.
Alan said: "The foetal control delivered by Bovela gives absolute confidence that cows will not produce PIs. This, alongside the drastically improved convenience will undoubtedly make Bovela the natural choice for many farmers, both on beef and dairy farms."
According to Boehringer, around 60% of cattle in the EU test positive for exposure to the BVD virus and, although BVD type 1 is currently the most common form, outbreaks of BVD type 2, were confirmed in 2013 and 2014 in Belgium, Germany and The Netherlands. BVD type 2 is generally a more serious disease, with high levels of mortality and while the virus has been identified in UK, it has not yet been identified as the cause of serious outbreaks of disease in cattle.
Alan said: "Bovela is the first and only vaccine in UK which has been proven to protect cattle from BVD type 1 and 2. It has been in development for 17 years and, gained a marketing authorisation following assessment of an unprecedented quantity of data generated in both beef and dairy herds.
"Work has looked at the efficacy of Bovela in preventing the production of PI calves and against type 1 and 2 BVD as well as confirming its efficacy in young calves as young as three months of age as their natural maternal protection wears off. Trials also confirmed vaccine safety generally and during various stages of pregnancy. We do not believe that any other BVD vaccine has been tested as rigorously."